Glimepiride 3 Mg

You should take this medicine with breakfast or the first main meal of the day. The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label.

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light.

Hypoglycemia, Nausea , Dizziness , Headache , Skin reactions.

Avoid preganancy and lactation (breastfeeding) while consuming this medicines.

Alcohol—Drinking alcohol may cause severe low blood sugar. counseling on contraception and pregnancy may be needed because of the problems that can occur in patients with diabetes during pregnancy. Travel—Keep your recent prescription and your medical history with you. Be prepared for an emergency as you would normally. Make allowances for changing time zones and keep your meal times as close as possible to your usual meal times. Too much glimepiride can cause low blood sugar (hypoglycemia) when it is used under certain conditions. Symptoms of low blood sugar must be treated before they lead to unconsciousness (passing out). Different people may feel different symptoms of low blood sugar. It is important that you learn which symptoms of low blood sugar you usually have so that you can treat it quickly. If symptoms of low blood sugar occur, eat glucose tablets or gel, corn syrup, honey, or sugar cubes; or drink fruit juice, non-diet soft drink, or sugar dissolved in water. This medicine may cause dizziness, drowsiness, or less alert than they are normally. Make sure you know how you react to this medicine before you drive, use machines, or do other jobs that require you to be alert or able to think well. Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Product Information: AMARYL(R) oral tablets, glimepiride oral tablets . Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2016. Badian M, Korn A, Lehr KH, et al: Determination of the absolute bioavailability of glimepiride (HOE 490), a new sulphonylurea. Int J Clin Pharmacol Ther Toxicol 1992; 30(11):481-482. Product Information: glimepiride oral tablets, glimepiride oral tablets. Accord Healthcare, Inc. (per DailyMed), Durham, NC, 2015.

Glimepiride is a sulfonylurea; it stimulates insulin release from functioning pancreatic beta cells by binding to the sulfonylurea receptor, leading to closure of the ATP-sensitive potassium channel, which results in insulin release and a subsequent decrease in blood glucose.

Anti Diabtetic